A nano-sized blending system comprising identical triblock copolymers with different hydrophobicity for fabrication of an anticancer drug nanovehicle with high stability and solubilizing capacity

References

• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi:10.1038/nrc.2016.10827834398
   PubMed Web of Science ®Google Scholar
• Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Controlled Release. 2015;200:138–157. doi:10.1016/j.jconrel.2014.12.030
   PubMed Web of Science ®Google Scholar
• Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol. 2007;2(12):751. doi:10.1038/nnano.2007.38718654426
   PubMed Web of Science ®Google Scholar
• Choi JY, Thapa RK, Yong CS, Kim JO. Nanoparticle-based combination drug delivery systems for synergistic cancer treatment. J Pharm Invest. 2016;46(4):325–339. doi:10.1007/s40005-016-0252-1
   Google Scholar
• Choi YH, Han H-K; JJoPI. Nanomedicines: current status and future perspectives in aspect of drug delivery and pharmacokinetics. J Pharm Invest. 2018;48(1):43–60. doi:10.1007/s40005-017-0370-4
   PubMedGoogle Scholar
• Allen C, Maysinger D, Eisenberg A. Nano-engineering block copolymer aggregates for drug delivery. Colloids Surf B. 1999;16(1–4):3–27. doi:10.1016/S0927-7765(99)00058-2
   Web of Science ®Google Scholar
• Hoang NH, Lim C, Sim T, et al. Characterization of a triblock copolymer, poly (ethylene glycol)-polylactide-poly (ethylene glycol), with different structures for anticancer drug delivery applications. Polym Bull. 2017;74(5):1595–1609. doi:10.1007/s00289-016-1791-3
   Web of Science ®Google Scholar
• Gong J, Chen M, Zheng Y, Wang S, Wang Y. Polymeric micelles drug delivery system in oncology. J Controlled Release. 2012;159(3):312–323. doi:10.1016/j.jconrel.2011.12.012
   PubMed Web of Science ®Google Scholar
• Oh KT, Bronich TK, Kabanov AV. Micellar formulations for drug delivery based on mixtures of hydrophobic and hydrophilic Pluronic® block copolymers. J Controlled Release. 2004;94(2):411–422. doi:10.1016/j.jconrel.2003.10.018
   PubMed Web of Science ®Google Scholar
• Lee ES, Oh YT, Youn YS, et al. Binary mixing of micelles using Pluronics for a nano-sized drug delivery system. Colloids Surf B. 2011;82(1):190–195. doi:10.1016/j.colsurfb.2010.08.033
   PubMed Web of Science ®Google Scholar
• Pitto-Barry A, Barry NPJPC. Pluronic® block-copolymers in medicine: from chemical and biological versatility to rationalisation and clinical advances. Nat Commun. 2014;5(10):3291–3297. doi:10.1038/ncomms429124518117
   PubMedGoogle Scholar
• Food U. Drug administration %J -02-20. Inactive ingredient search for approved drug products; 2017 Available from: https://www.accehttps://www.accessdata.fda.gov/scripts/cder/iig/index.Cfm?event=browseByLetter.page&Letter=Pssdata.fda.gov/scripts/cder/iig/index.Cfm?event=browseByLetter.page&Letter=P. Accessed March 22, 2019.
   Google Scholar
• Valle JW, Armstrong A, Newman C, et al. A phase 2 study of SP1049C, doxorubicin in P-glycoprotein-targeting pluronics, in patients with advanced adenocarcinoma of the esophagus and gastroesophageal junction. Invest New Drugs. 2011;29(5):1029–1037. doi:10.1007/s10637-010-9399-120179989
   PubMed Web of Science ®Google Scholar
• Lilletvedt M, Smistad G, Tønnesen H, Høgset A, Kristensen S. Solubilization of the novel anionic amphiphilic photosensitizer TPCS2a by nonionic Pluronic block copolymers. Eur J Pharm Sci. 2011;43(3):180–187. doi:10.1016/j.ejps.2011.04.00421530656
   PubMedGoogle Scholar
• Magnusson G, Olsson T, Nyberg J-A. Toxicity of pluronic f-68. Toxicol Lett. 1986;30(3):203–207.3705104
   PubMed Web of Science ®Google Scholar
• Sim T, Kim JE, Hoang NH, et al. Development of a docetaxel micellar formulation using poly (ethylene glycol)–polylactide–poly (ethylene glycol)(PEG–PLA–PEG) with successful reconstitution for tumor targeted drug delivery. Drug Delivery. 2018;25(1):1362–1371.29869563
   PubMed Web of Science ®Google Scholar
• Song H-T, Hoang NH, Yun JM, et al. Development of a new tri-block copolymer with a functional end and its feasibility for treatment of metastatic breast cancer. Colloids Surf B. 2016;144:73–80. doi:10.1016/j.colsurfb.2016.04.002
   PubMed Web of Science ®Google Scholar
• Hoang NH, Lim C, Sim T, et al. Characterization of a triblock copolymer, poly (ethylene glycol)-polylactide-poly (ethylene glycol), with different structures for anticancer drug delivery applications. Polym Bull. 2017;74(5):1595–1609.
   Web of Science ®Google Scholar
• Hoang NH, Lim C, Sim T, Oh KT. Triblock copolymers for nano-sized drug delivery systems. J Pharm Invest. 2017;47(1):27–35. doi:10.1007/s40005-016-0291-7
   Google Scholar
• Lysenko EA, Bronich TK, Slonkina EV, Eisenberg A, Kabanov VA, Kabanov AV. Block ionomer complexes with polystyrene core-forming block in selective solvents of various polarities. 1. Solution behavior and self-assembly in aqueous media. Macromolecules. 2002;35(16):6351–6361. doi:10.1021/ma020048s
   Web of Science ®Google Scholar
• Han SK, Na K, Bae YH. Sulfonamide based pH-sensitive polymeric micelles: physicochemical characteristics and pH-dependent aggregation. Colloids Surf A. 2003;214(1–3):49–59. doi:10.1016/S0927-7757(02)00389-8
   Google Scholar
• Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov. 2003;2(5):347–360. doi:10.1038/nrd108812750738
   PubMed Web of Science ®Google Scholar
• Oh NM, Oh KT, Youn YS, Lee ES. Artificial nano-pin as a temporal molecular glue for the targeting of acidic tumor cells. Polym Adv Technol. 2014;25(8):842–850. doi:10.1002/pat.3315
   Web of Science ®Google Scholar
• Oh NM, Oh KT, Youn YS, et al. Poly(L-aspartic acid) nanogels for lysosome-selective antitumor drug delivery. Colloids Surf B. 2013;101:298–306. doi:10.1016/j.colsurfb.2012.07.013
   PubMed Web of Science ®Google Scholar
• Kwag DS, Oh KT, Lee ES. Facile synthesis of multilayered polysaccharidic vesicles. J Controlled Release. 2014;187:83–90. doi:10.1016/j.jconrel.2014.05.032
   PubMed Web of Science ®Google Scholar
• He C, Hu Y, Yin L, Tang C, Yin C. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials. 2010;31(13):3657–3666. doi:10.1016/j.biomaterials.2010.01.06520138662
   PubMed Web of Science ®Google Scholar
• Kwon GS, Okano T. Polymeric micelles as new drug carriers. Adv Drug Del Rev. 1996;21(2):107–116. doi:10.1016/S0169-409X(96)00401-2
   Web of Science ®Google Scholar
• Kim JH, Oh YT, Lee KS, Yun JM, Park BT, Oh KT. Development of a pH-Sensitive Polymer Using Poly (aspartic acid-graft-imidazole)-block-Poly (ethylene glycol) for acidic pH targeting systems. Macromol Res. 2011;19(5):453–460. doi:10.1007/s13233-011-0502-z
   Web of Science ®Google Scholar
• Lee ES, Kim JH, Sim T, et al. A feasibility study of a pH sensitive nanomedicine using doxorubicin loaded poly(aspartic acid-graft-imidazole)-block-poly(ethylene glycol) micelles. J Mater Chem B. 2014;2(9):1152–1159. doi:10.1039/c3tb21379j
   PubMed Web of Science ®Google Scholar
• Torchilin V. Targeted polymeric micelles for delivery of poorly soluble drugs. Cell Mol Life Sci. 2004;61(19–20):2549–2559. doi:10.1007/s00018-004-4153-515526161
   PubMed Web of Science ®Google Scholar
• Lee J, Cho EC, Cho K. Incorporation and release behavior of hydrophobic drug in functionalized poly (D, L-lactide)-block–poly (ethylene oxide) micelles. J Controlled Release. 2004;94(2):323–335. doi:10.1016/j.jconrel.2003.10.012
   PubMed Web of Science ®Google Scholar
• Verma A, Stellacci F. Effect of surface properties on nanoparticle–cell interactions. Small. 2010;6(1):12–21. doi:10.1002/smll.20090115819844908
   PubMed Web of Science ®Google Scholar
• Ma P, Mumper RJ. Anthracycline nano-delivery systems to overcome multiple drug resistance: A comprehensive review. Nano Today. 2013;8(3):313–331. doi:10.1016/j.nantod.2013.04.00623888183
   PubMed Web of Science ®Google Scholar
• Haag R. Supramolecular drug-delivery systems based on polymeric core–shell architectures. Angew Chem Int Ed. 2004;43(3):278–282. doi:10.1002/anie.200301694
   PubMed Web of Science ®Google Scholar
• De Verdiere AC, Dubernet C, Nemati F, Poupon M, Puisieux F, Couvreur P. Uptake of doxorubicin from loaded nanoparticles in multidrug-resistant leukemic murine cells. Cancer Chemother Pharmacol. 1994;33(6):504–508.8137462
   PubMed Web of Science ®Google Scholar
• Wong HL, Bendayan R, Rauth AM, Xue HY, Babakhanian K, Wu XY. A mechanistic study of enhanced doxorubicin uptake and retention in multidrug resistant breast cancer cells using a polymer-lipid hybrid nanoparticle system. J Pharmacol Exp Ther. 2006;317(3):1372–1381. doi:10.1124/jpet.106.10115416547167
   PubMed Web of Science ®Google Scholar
• Yang C, Sun Y, Zhang L. Dissipative particle dynamics study on aggregation of MPEG-PAE-PLA block polymer micelles loading doxorubicine. Chin J Chem. 2012;30(9):1980–1986. doi:10.1200/JCO.2011.39.2381
   Web of Science ®Google Scholar
• Huh KM, Lee SC, Cho YW, Lee J, Jeong JH, Park K. Hydrotropic polymer micelle system for delivery of paclitaxel. J Controlled Release. 2005;101(1–3):59–68. doi:10.1016/j.jconrel.2004.07.003
   PubMed Web of Science ®Google Scholar
• Zhu C, Jung S, Luo S, et al. Co-delivery of siRNA and paclitaxel into cancer cells by biodegradable cationic micelles based on PDMAEMA–PCL–PDMAEMA triblock copolymers. Biomaterials. 2010;31(8):2408–2416. doi:10.1016/j.biomaterials.2009.11.07719963269
   PubMed Web of Science ®Google Scholar
• Kumar R, Kulkarni A, Nagesha DK, Sridhar S. In vitro evaluation of theranostic polymeric micelles for imaging and drug delivery in cancer. Theranostics. 2012;2(7):714–722. doi:10.7150/thno.392722896773
   PubMedGoogle Scholar
• Melguizo C, Cabeza L, Prados J, et al. Enhanced antitumoral activity of doxorubicin against lung cancer cells using biodegradable poly (butylcyanoacrylate) nanoparticles. Drug Des Devel Ther. 2015;9:6433.
   PubMed Web of Science ®Google Scholar
• Feitosa E, Winnik F. Interaction between Pluronic F127 and dioctadecyldimethylammonium bromide (DODAB) vesicles studied by differential scanning calorimetry. Langmuir. 2010;26(23):17852–17857. doi:10.1021/la102603a21049920
   PubMedGoogle Scholar
• Maeda H, Wu J, Sawa T, Matsumura Y, Hori K. Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Controlled Release. 2000;65(1):271–284.
   PubMed Web of Science ®Google Scholar
• Fang J, Nakamura H, Maeda H. The EPR effect: unique features of tumor blood vessels for drug delivery, factors involved, and limitations and augmentation of the effect. Adv Drug Del Rev. 2011;63(3):136–151. doi:10.1016/j.addr.2010.04.009
   PubMed Web of Science ®Google Scholar
• Zhang X, Burt HM, Mangold G, et al. Anti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel. Anticancer Drugs. 1997;8(7):696–701.9311446
   PubMed Web of Science ®Google Scholar
• Huang S, Shao K, Kuang Y, et al. Tumor targeting and microenvironment-responsive nanoparticles for gene delivery. Biomaterials. 2013;34(21):5294–5302. doi:10.1016/j.biomaterials.2013.03.04323562171
   PubMed Web of Science ®Google Scholar
• Kim SH, Lee JE, Sharker SM, Jeong JH, In I, Park SY. In vitro and in vivo tumor targeted photothermal cancer therapy using functionalized graphene nanoparticles. Biomacromolecules. 2015;16(11):3519–3529. doi:10.1021/acs.biomac.5b0094426451914
   PubMed Web of Science ®Google Scholar